Biotech contractor settles for $9.8 million with DOJ over alleged cybersecurity lapses

Illumina Inc. settled a $9.8 million deal with the U.S. government over cybersecurity flaws in its genomic sequencing systems sold to federal agencies. The case highlights the importance of cybersecurity compliance among government contractors handling sensitive genetic data. #FalseClaimsAct #Illumina #CybersecurityStandards #GenomicSystems #FederalContracts

Keypoints

Illumina agreed to pay $9.8 million to settle cybersecurity allegations with the U.S. government.
The company was accused of selling genomic products with unresolved software vulnerabilities.
Illumina allegedly failed to incorporate cybersecurity measures into its software development process.
The case was initiated under the False Claims Act, emphasizing accountability for cybersecurity compliance.
A whistleblower from Illumina played a role in bringing the issues to light, leading to the settlement.